Collectively, ATM deficiency may be associated with the progression of PC cells by disturbing cell-cycle checkpoint control and the apoptotic pathway, resulting in chemoresistance and poor prognosis in patients with PC. The gene discussed is ATM; the disease is pachyonychia congenita.